RxDoctor Payments Data

Jorge Benito, MD

Psychiatry · South Miami, FLNPI 1356384606

Payments from drug & device makers

$39,839in general payments, 2019–2025

Across 129 payments — averaging $308.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eisai Inc.$25K
  • E.r. Squibb & Sons, L.L.C.$10K
  • Medical Device Business Services, Inc.$2K
  • Stryker$1K
  • Johnson & Johnson$667
  • Alkermes, Inc.$491
  • plus $872 from 7 others

What the payments were for

  • Travel & lodging$1,07921%
  • Food & beverage$2,10340%
  • Education$2,04539%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,839 in reported general payments places this provider in the 90th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$198,413
Medicare patients
233
Services billed
1,545

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole24$68,388
Invega SustennaPaliperidone Palmitate20$58,488
NamzaricMemantine Hcl/Donepezil Hcl12$7,783
Aripiprazole26$5,590
Fluphenazine Decanoate14$1,683
Quetiapine Fumarate62$1,411
Divalproex Sodium52$1,030
Risperidone71$932
Trazodone Hcl98$813
Haloperidol Decanoate20$781
Clozapine18$721
Olanzapine39$643
Escitalopram Oxalate49$607
Temazepam34$484
Paroxetine Hcl18$441

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$191$68,38824 claims
Johnson & JohnsonInvega Sustenna$667$58,48820 claims
AbbVieNamzaric$167$7,78312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in South Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →